Premium
The risks and benefits of antithrombotic therapy in chronic atrial fibrillation
Author(s) -
Hankey Graeme J,
Gray Natalie J
Publication year - 1996
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1996.tb122211.x
Subject(s) - antithrombotic , medicine , atrial fibrillation , aspirin , warfarin , intensive care medicine , intervention (counseling) , adverse effect , cardiology , psychiatry
As the risks of adverse effects of warfarin and aspirin in certain patients with chronic atrial fibrillation are high, intervention with these agents should be targeted towards those who will derive most benefit. Clearer guidelines are emerging to identify those patients and to standardise current prescribing practices.